Health-related quality of life after intensive care unit discharge: A comparison between 2 standard antibiotic regimens

M.A. Aldeyab, M.P. Kearney, M.G. Scott, J. Hanley, J.C. McElnay

Research output: Contribution to journalLetter

LanguageEnglish
Pages807-808
Number of pages2
JournalInfection Control and Hospital Epidemiology
Volume30
Issue number8
DOIs
Publication statusPublished - Aug 2009

Keywords

  • amoxicillin
  • antibiotic agent
  • ciprofloxacin
  • metronidazole
  • piperacillin plus tazobactam
  • add on therapy
  • anaerobic infection
  • antibiotic resistance
  • antibiotic therapy
  • APACHE
  • comparative study
  • health care
  • health care policy
  • health status
  • hospital discharge
  • human
  • intensive care unit
  • letter
  • methicillin resistant Staphylococcus aureus
  • methicillin resistant Staphylococcus aureus infection
  • nonhuman
  • quality of life
  • visual analog scale
  • Anti-Bacterial Agents
  • Ciprofloxacin
  • Drug Resistance, Bacterial
  • Health Status
  • Humans
  • Intensive Care Units
  • Outcome Assessment (Health Care)
  • Patient Discharge
  • Penicillanic Acid
  • Piperacillin
  • Quality of Life
  • Questionnaires

Cite this

Aldeyab, M.A. ; Kearney, M.P. ; Scott, M.G. ; Hanley, J. ; McElnay, J.C. / Health-related quality of life after intensive care unit discharge: A comparison between 2 standard antibiotic regimens. In: Infection Control and Hospital Epidemiology. 2009 ; Vol. 30, No. 8. pp. 807-808.
@article{fd77bffeaac44adfb52ff9920ec0d7b2,
title = "Health-related quality of life after intensive care unit discharge: A comparison between 2 standard antibiotic regimens",
keywords = "amoxicillin, antibiotic agent, ciprofloxacin, metronidazole, piperacillin plus tazobactam, add on therapy, anaerobic infection, antibiotic resistance, antibiotic therapy, APACHE, comparative study, health care, health care policy, health status, hospital discharge, human, intensive care unit, letter, methicillin resistant Staphylococcus aureus, methicillin resistant Staphylococcus aureus infection, nonhuman, quality of life, visual analog scale, Anti-Bacterial Agents, Ciprofloxacin, Drug Resistance, Bacterial, Health Status, Humans, Intensive Care Units, Outcome Assessment (Health Care), Patient Discharge, Penicillanic Acid, Piperacillin, Quality of Life, Questionnaires",
author = "M.A. Aldeyab and M.P. Kearney and M.G. Scott and J. Hanley and J.C. McElnay",
note = "Export Date: 15 September 2018 CODEN: ICEPE Correspondence Address: McElnay, J. C.; Department of Pharmacy Practice, Clinical and Practice Research Group, Queen's University Belfast, Belfast BT9 7BL, United Kingdom; email: j.mcelnay@qub.ac.uk Chemicals/CAS: amoxicillin, 26787-78-0, 34642-77-8, 61336-70-7; ciprofloxacin, 85721-33-1; metronidazole, 39322-38-8, 443-48-1; Anti-Bacterial Agents; Ciprofloxacin, 85721-33-1; Penicillanic Acid, 87-53-6; Piperacillin, 61477-96-1; piperacillin-tazobactam combination product, 157044-21-8 Tradenames: tazocin References: Kollef, M.H., Fraser, V.J., Antibiotic resistance in the intensive care unit (2001) Ann Intern Med, 134, pp. 298-314; Carlet, J., Ben Ali, A., Chalfine, A., Epidemiology and control of antibiotic resistance in the intensive care unit (2004) Curr Opin Infect Dis, 17, pp. 309-316; Mcgowan Jr., J.E., Antimicrobial resistance in hospital organisms and its relation to antibiotic use (1983) Rev Infect Dis, 5, pp. 1033-1048; Muller, A.A., Mauny, F., Bertin, M., Relationship between spread of methicillin-resistant Staphylococcus aureus and antimicrobial use in a French university hospital (2003) Clin Infect Dis, 36, pp. 971-978; Monnet, D.L., Mackenzie, F.M., Lopez-Lozano, J.M., Antimicrobial drug use and methicillin-resistant Staphylococcus aureus, Aberdeen, 1996-2000 (2004) Emerg Infect Dis, 10, pp. 1432-1441; Aldeyab, M.A., Monnet, D.L., L{\'o}pez-Lozano, J.M., Modelling the impact of antibiotic use and infection control practices on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus: A time-series analysis (2008) J Antimicrob Chemother, 62, pp. 593-600; Aldeyab, M.A., Hughes, C.M., Kearney, M.P., Comparison of the effect of ciprofloxacin and Tazocin on the incidence of meticillin-resistant Staphylococcus aureus (MRSA) in an intensive care unit (2008) Int J Antimicrob Agents, 32, pp. 499-504; EuroQol: A new facility for the measurement of health related quality of life (1990) Health Policy, 16, pp. 199-208. , EuroQol Group; Dolan, P., Modeling valuations for EuroQol health states (1997) Med Care, 35, pp. 1095-1108",
year = "2009",
month = "8",
doi = "10.1086/599001",
language = "English",
volume = "30",
pages = "807--808",
journal = "Infection Control and Hospital Epidemiology",
issn = "0899-823X",
publisher = "Cambridge University Press",
number = "8",

}

Health-related quality of life after intensive care unit discharge: A comparison between 2 standard antibiotic regimens. / Aldeyab, M.A.; Kearney, M.P.; Scott, M.G.; Hanley, J.; McElnay, J.C.

In: Infection Control and Hospital Epidemiology, Vol. 30, No. 8, 08.2009, p. 807-808.

Research output: Contribution to journalLetter

TY - JOUR

T1 - Health-related quality of life after intensive care unit discharge: A comparison between 2 standard antibiotic regimens

AU - Aldeyab, M.A.

AU - Kearney, M.P.

AU - Scott, M.G.

AU - Hanley, J.

AU - McElnay, J.C.

N1 - Export Date: 15 September 2018 CODEN: ICEPE Correspondence Address: McElnay, J. C.; Department of Pharmacy Practice, Clinical and Practice Research Group, Queen's University Belfast, Belfast BT9 7BL, United Kingdom; email: j.mcelnay@qub.ac.uk Chemicals/CAS: amoxicillin, 26787-78-0, 34642-77-8, 61336-70-7; ciprofloxacin, 85721-33-1; metronidazole, 39322-38-8, 443-48-1; Anti-Bacterial Agents; Ciprofloxacin, 85721-33-1; Penicillanic Acid, 87-53-6; Piperacillin, 61477-96-1; piperacillin-tazobactam combination product, 157044-21-8 Tradenames: tazocin References: Kollef, M.H., Fraser, V.J., Antibiotic resistance in the intensive care unit (2001) Ann Intern Med, 134, pp. 298-314; Carlet, J., Ben Ali, A., Chalfine, A., Epidemiology and control of antibiotic resistance in the intensive care unit (2004) Curr Opin Infect Dis, 17, pp. 309-316; Mcgowan Jr., J.E., Antimicrobial resistance in hospital organisms and its relation to antibiotic use (1983) Rev Infect Dis, 5, pp. 1033-1048; Muller, A.A., Mauny, F., Bertin, M., Relationship between spread of methicillin-resistant Staphylococcus aureus and antimicrobial use in a French university hospital (2003) Clin Infect Dis, 36, pp. 971-978; Monnet, D.L., Mackenzie, F.M., Lopez-Lozano, J.M., Antimicrobial drug use and methicillin-resistant Staphylococcus aureus, Aberdeen, 1996-2000 (2004) Emerg Infect Dis, 10, pp. 1432-1441; Aldeyab, M.A., Monnet, D.L., López-Lozano, J.M., Modelling the impact of antibiotic use and infection control practices on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus: A time-series analysis (2008) J Antimicrob Chemother, 62, pp. 593-600; Aldeyab, M.A., Hughes, C.M., Kearney, M.P., Comparison of the effect of ciprofloxacin and Tazocin on the incidence of meticillin-resistant Staphylococcus aureus (MRSA) in an intensive care unit (2008) Int J Antimicrob Agents, 32, pp. 499-504; EuroQol: A new facility for the measurement of health related quality of life (1990) Health Policy, 16, pp. 199-208. , EuroQol Group; Dolan, P., Modeling valuations for EuroQol health states (1997) Med Care, 35, pp. 1095-1108

PY - 2009/8

Y1 - 2009/8

KW - amoxicillin

KW - antibiotic agent

KW - ciprofloxacin

KW - metronidazole

KW - piperacillin plus tazobactam

KW - add on therapy

KW - anaerobic infection

KW - antibiotic resistance

KW - antibiotic therapy

KW - APACHE

KW - comparative study

KW - health care

KW - health care policy

KW - health status

KW - hospital discharge

KW - human

KW - intensive care unit

KW - letter

KW - methicillin resistant Staphylococcus aureus

KW - methicillin resistant Staphylococcus aureus infection

KW - nonhuman

KW - quality of life

KW - visual analog scale

KW - Anti-Bacterial Agents

KW - Ciprofloxacin

KW - Drug Resistance, Bacterial

KW - Health Status

KW - Humans

KW - Intensive Care Units

KW - Outcome Assessment (Health Care)

KW - Patient Discharge

KW - Penicillanic Acid

KW - Piperacillin

KW - Quality of Life

KW - Questionnaires

U2 - 10.1086/599001

DO - 10.1086/599001

M3 - Letter

VL - 30

SP - 807

EP - 808

JO - Infection Control and Hospital Epidemiology

T2 - Infection Control and Hospital Epidemiology

JF - Infection Control and Hospital Epidemiology

SN - 0899-823X

IS - 8

ER -